A three-ingredient ectoparasite and endoparasite control for dogs
Provides efficacy against fleas and ticks for 5 weeks and against Dermacentor reticulatus for 4 weeks.
Composition.
Active ingredients:
• sarolaner;
• moxidectin;
• pyrantel embonate.
Pharmaceutical form: chewable tablet.
The drug is presented in the form of tablets with different dosages, corresponding to different ranges of dog body weight:
Dog 1.25-2.5 kg -3/0.06/12.5 mg
Dog 2.5-5 kg - 6/0.12/25 mg
Dog 5-10 kg -12/0.24/50 mg
Dog 10-20 kg -24/0.48/100 mg
Dog 20-40 kg -48/0.96/200 mg
Dog 40-60 kg -72/1.44/300 mg
The drug is used only in dogs.
Therapeutic indications
It is effective simultaneously against ticks, fleas and gastrointestinal nematodes. If there is no risk of mixed invasion, it is advisable to choose an antiparasitic agent with a narrower spectrum of action.
The drug is used:
• For the treatment of tick infestations;
• For the treatment of flea infestations;
• For the treatment of gastrointestinal nematode infestations;
• For the treatment of angiostrongylosis caused by Angiostrongylus vasorum;
• For the prevention of infection caused by Dirofilaria immitis.
Mechanism of action
Sarolaner is an insecticidal and acaricidal substance of the isoxazoline group. It acts on the nervous system of parasites and causes their neuromuscular dysfunction and death.
Moxidectin is a macrocyclic lactone and acts on the neuromuscular system of nematodes.
Pyrantel embonate is an anthelmintic substance of the tetrahydropyrimidine group and is active against gastrointestinal nematodes.
Important application principle
The preparation is particularly intended for cases where the dog simultaneously has or is at risk of mixed parasitic infestation.
If there is no risk of mixed infestation, it is advisable to choose an antiparasitic agent with a narrower spectrum of action.
Contraindications
Do not use in cases of known hypersensitivity to the active substances or excipients.
Special warnings and precautions
When using drugs of the isoxazolines group, neurological disorders, including tremors, ataxia or seizures, may occur very rarely.
Particular caution is required in animals with a history of neurological disorders or seizures.
Adverse reactions
Mainly mild and transient gastrointestinal disorders, including vomiting and diarrhea, as well as lethargy, loss of appetite and other transient clinical signs.
Use during pregnancy and lactation should be agreed with a veterinarian
No clinically significant interactions with other veterinary medicinal products have been identified
Storage
Keep out of the reach of children.
At a temperature below 30°C.
